Annovis Bio Stock (NYSE: ANVS) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 24.318K / 488.521K |
Day Range | - - - |
52 Wk Range | 4.790 - 22.490 |
Market Cap | $67.787M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NYSE |
RSI | 42 |
Short Interest | 17.7% |
Days to Cover | 9.29 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Annovis Bio (NYSE: ANVS) through any online brokerage.
Other companies in Annovis Bio’s space includes: CARISMA Therapeutics (NASDAQ:CARM), Aligos Therapeutics (NASDAQ:ALGS), CollPlant Biotechnologies (NASDAQ:CLGN), Precision BioSciences (NASDAQ:DTIL) and vTv Therapeutics (NASDAQ:VTVT).
The latest price target for Annovis Bio (NYSE: ANVS) was reported by Canaccord Genuity on Tuesday, April 30, 2024. The analyst firm set a price target for 26.00 expecting ANVS to rise to within 12 months (a possible 322.74% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Annovis Bio (NYSE: ANVS) is $6.1504 last updated Today at May 10, 2024 at 8:32 AM EDT.
There are no upcoming dividends for Annovis Bio.
Annovis Bio’s Q1 earnings are confirmed for Tuesday, May 21, 2024.
There is no upcoming split for Annovis Bio.
Annovis Bio is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.